This article explores the pharmacologic rationale for monitoring hourly vital signs and the subsequent effects of disturbances in sleep patterns in the patient who receives a constant infusion of IV NTG. Although some patients may require additional vasoactive drugs to maintain stability of vital signs, this article addresses the monitoring practices for IV NTG in patients with acute MI, unstable angina, or CHF who do not require other vasoactive drugs.
Skip Nav Destination
- Views Icon Views
- Share Icon Share
L Ardire; Iv NTG: monitoring vital signs hourly versus every two hours. Crit Care Nurse 1 October 1990; 10 (9): 52–56. doi: https://doi.org/10.4037/ccn19188.8.131.52
Download citation file: